Zag Bio

Drug Delivery · Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a therapeutic platform intended to offer precise medicines for immune-mediated diseases. Zag Bio is based in Cambridge, MA and was founded in 2022. Its last reported valuation was $25 million in Jul 2023. It has raised $102 million across 1 recorded round; the latest was an $80 million Series A in Oct 2025.

Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$102.0M
Last round
Early Stage VC (Series A)
Oct 2025
Cap table — not yet on record

Zag Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Zag Bio with a free account
  • ·The complete investor list: 17 names
  • ·Watch Zag Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Zag Bio

Where does Zag Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Zag Bio's 1 recorded funding rounds.